New McMaster-made drug candidate shows promise as a brain cancer treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 02:15 ET (22-Jun-2026 06:15 GMT/UTC)
A sweat-monitoring wearable device developed by UC Irvine researchers enables real-time and continuous tracking of a variety of health conditions through sweat analysis. The sensor is designed to be worn continuously outside of laboratory or clinical settings and can detect molecules in perspiration that are signs of stress, cancer, kidney disease and mental health issues. The project was funded by the UC Irvine Samueli School of Engineering.
Occupational burnout is a growing threat to care quality, workforce retention and physician well-being. Pregnant and postpartum physicians-in-training are especially at risk, facing stigma, limited support, and physical demands, alongside major role transitions and increased responsibilities at home. Investigators at Mass General Brigham conducted a randomized controlled trial showing that a parental support package consisting of a wearable breast pump, digital perinatal care access, a smart bassinet and faculty mentorship significantly reduces burnout in physician trainees. The results are published in JAMA.
Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the tumor microenvironment (TME) of early-stage triple-negative breast cancer (TNBC) tissues, identifying specific macrophage subtypes associated with chemotherapy response.
A team of Rice University bioengineers has developed a new way to create highly realistic “mock” patient samples that could help accelerate the development of faster, more accessible cervical cancer screening tests for low-resource settings. The study, led by researchers in Rice’s Department of Bioengineering in collaboration with Emory University and clinicians at The University of Texas MD Anderson Cancer Center, addresses a critical bottleneck in global health: the lack of reliable, real-world samples needed to design and validate next-generation point-of-care screening tools for high-risk human papillomavirus, the virus responsible for nearly all cervical cancers. The research was recently published in the Journal of Medical Virology.